Clinical Trial Update: Radiotherapy Combined With Fluzopanib and Abiraterone Acetate Tablets (II) Treatment for mCRPC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating radiotherapy in combination with fluzopanib and abiraterone acetate for metastatic castration-resistant prostate cancer; recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Abiraterone acetate tablets (abiraterone acetate)
• Fluzopanib (fluzopanib)

Snippet

Sponsor: Jianbin Bi | Conditions: Metastatic Castration-resistant Prostate Cancer | Phase 2 | Status: RECRUITING